67
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Psychological Distress and Physical Pain Appear To Have No Short-Term Adverse Impact on Plasma HIV-1 RNA Levels in Patients on Successful HAART

, , , , , , , , & show all
Pages 262-271 | Published online: 02 Feb 2015

REFERENCES

  • Herbert TB, Cohen S. Stress and immunity in humans: a meta-analytic review. Psychosom Med. 1993;55:364–379.
  • Glaser R, Rabin B, Chesney M, Cohen S, Natelson B. Stress-induced immunomodulation: implications for infec-tious diseases? JAMA. 1999;281: 2268–2270.
  • Page GG. The immune-suppressive effects of pain. Adv Exp Med Biol. 2003;521:117–125.
  • Burack JH, Barrett DC, Stall RD, Chesney MA, Ekstrand ML, Coates TJ. Depressive symptoms and CD4 lympho-cyte decline among HIV-infected men. JAMA. 1993;270:2568–2573.
  • Page-Shafer K, Delorenze GN, Satariano WA, Winkelstein W Jr. Comorbidity and survival in HIV-infected men in the San Francisco Men's Health Survey. Ann Epidemiol. 1996;6:420–430.
  • Leserman J, Petitto JM, Perkins DO, Folds JD, Golden RN, Evans DL. Severe stress, depressive symptoms, and changes in lymphocyte subsets in human immunodefi-ciency virus-infected men. A 2-year follow-up study. Arch Gen Psychiatry. 1997;54:279–285.
  • Ickovics JR, Hamburger ME, Vlahov D, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA. 2001;285:1466–1474.
  • Leserman J, Petitto JM, Golden RN, et al. Impact of stress-ful life events, depression, social support, coping, and cortisol on progression to AIDS. Am J Psychiatry. 2000;157:1221–1228.
  • Leserman J, Jackson ED, Petitto JM, et al. Progression to AIDS: the effects of stress, depressive symptoms, and social support. Psychosom Med. 1999;61:397–406.
  • Cole SW, Naliboff BD, Kemeny ME, Griswold MP, Fahey JL, Zack JA. Impaired response to HAART in HIV-infected individuals with high autonomic nervous system activity. Proc Natl Acad Sci USA. 2001;98(22):12695–12700.
  • Cole SW, Kemeny ME, Fahey JL, Zack JA, Naliboff BD. Psychological risk factors for HIV pathogenesis: mediation by the autonomic nervous system. Biol Psychiatry. 2003;54(12)1 444–1456.
  • Rabkin JG, Williams JB, Remien RH, Goetz R, Kertzner R, Gorman JM. Depression, distress, lymphocyte subsets, and human immunodeficiency virus symptoms on two oc-casions in HIV-positive homosexual men. Arch Gen Psy-chiatry. 199148: 111–119.
  • Lyketsos CG, Hoover DR, Guccione M, et al. Depressive symptoms as predictors of medical outcomes in HIV infec-tion. Multicenter AIDS Cohort Study. JAMA. 1993;270: 2563–2567.
  • Katon W, Von Korff M, Lin E, et al. Collaborative manage-ment to achieve treatment guidelines. Impact on depres-sion in primary care. JAMA. 1995;273:1026–1031.
  • Cole SW, Korin YD, Fahey JL, Zack JA. Norepinephrine accelerates HIV replication via protein kinase A-dependent effects on cytokine production. J Immunol. 1998;161:610–616.
  • Cole SW, Jamieson BD, Zack JA. cAMP up-regulates cell surface expression of lymphocyte CXCR4: implications for chemotaxis and HIV-1 infection. J Immunol. 1999;162: 1392–1400.
  • Evans DL, Ten Have TR, Douglas SD, et al. Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection. Am J Psychiatry. 2002;159:1752–1759.
  • Motivala SJ, Hurwitz BE, Llabre MM, et al. Psychological distress is associated with decreased memory helper T-cell and B-cell counts in pre-AIDS HIV seropositive men and women but only in those with low viral load. Psychosom Med. 2003;65:627–635.
  • Nettles RE, Kieffer TL, Kwon P, et al. Intermittent HIV-1 viremia (blips) and drug resistance in patients receiving HAART. JAMA. 2005;293:817–829.
  • Berwick DM, Murphy JM, Goldman PA, Ware JE Jr., Barsky AJ, Weinstein MC. Performance of a five-item men-tal health screening test. Med Care. 199129: 169–176.
  • Holmes WC. A short, psychiatric, case-finding measure for HIV seropositive outpatients: performance characteristics of the 5-item mental health subscale of the SF-20 in a male, seropositive sample. Med Care. 1998;36:237–243.
  • Ware JE Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–483.
  • Lamotte C, Peytavin G, Farinotti R. Determination of nelfinavir, a potent HIV protease inhibitor, and its active metabolite M8 in human plasma by high-performance liq-uid chromatography with photodiode-array detection. J Chromatogr B Biomed Sci Appl. 1999;735:159–170.
  • Pay JW, Rowland LS, Korpalski DJ. HPLC-UV method for the quantitation of nevirapine in biological matrices follow-ing solid phase extraction. J Pharm Biomed Anal. 1999;20:91–98.
  • Guidelines for the Use of Antiretroviral Agents in HIV-in-fected Adults and Adolescents, October 29, 2004. Avail-able at http://www.aidsinfo.nih.gov/. Accessed March 8, 2005.
  • Gordillo V, del Amo J, Soriano V, Gonzalez-Lahoz J. Sociodemographic and psychological variables influenc-ing adherence to antiretroviral therapy. AIDS. 1999; 13:1763–1769.
  • Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21–30.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.